Would switching drugs help?

Possibly, and possibly not — low blood sugar is listed on the labels of most drugs in this class, so a switch is not a way out of it by default. What a switch does change is the price: every verified route to each molecule is priced on this site with the date each figure was read.

← All Wegovy side effects

Does Wegovy cause low blood sugar?

Bottom line

Yes. Low blood sugar is listed among the common adverse reactions on Wegovy's own FDA label, published 2026-06-30. It does not track the dose schedule, so it does not arrive with each increase and does not settle between them.

No clinician has reviewed this page. Every clinical statement on it is drawn from the FDA label or the trial cited beside it, and every price carries the date it was verified — but that is sourcing, not medical review, and the two are not the same thing. What we do and do not check · Who checked the price

Last updated 2026-06-30 — the FDA label this page quotes. Read and dated by Alex Seot.

Does Wegovy cause low blood sugar?

Yes, and it is on the label rather than only in reports: low blood sugar appears among the common adverse reactions in Wegovy's FDA prescribing information, published 2026-06-30. Listed means it was seen often enough in the trials to be printed, not that everyone gets it. By itself, rarely. These drugs prompt insulin release in response to a meal rather than regardless of one, so on their own they do not usually push blood sugar down far. The risk is the combination: the labels that list hypoglycaemia list it for people also taking insulin or a sulfonylurea, where the two effects add up. That is why the label's own wording ties it to type 2 diabetes rather than to everyone. It does not track the dose schedule, so it does not arrive with each increase and does not settle between them. What helps, in the order worth trying: knowing whether anything else you take is insulin or a sulfonylurea — glipizide, glimepiride, glyburide. If so, this is a conversation with the prescriber before the next dose increase, not after a bad episode; carrying fast sugar if you are on either of those; recognising the pattern: sweating, shakiness, sudden hunger, confusion. On these drugs it can be mistaken for the ordinary nausea; testing rather than guessing, if you have a meter. It stops being ordinary at a specific line: confusion, seizure, or being unable to treat it yourself. Anyone on insulin or a sulfonylurea starting one of these should have the doses of those reviewed rather than left as they were.

Why Wegovy does this

By itself, rarely. These drugs prompt insulin release in response to a meal rather than regardless of one, so on their own they do not usually push blood sugar down far. The risk is the combination: the labels that list hypoglycaemia list it for people also taking insulin or a sulfonylurea, where the two effects add up. That is why the label's own wording ties it to type 2 diabetes rather than to everyone.

What actually helps

1Knowing whether anything else you take is insulin or a sulfonylurea — glipizide, glimepiride, glyburide. If so, this is a conversation with the prescriber before the next dose increase, not after a bad episode.
2Carrying fast sugar if you are on either of those.
3Recognising the pattern: sweating, shakiness, sudden hunger, confusion. On these drugs it can be mistaken for the ordinary nausea.
4Testing rather than guessing, if you have a meter.

Nausea, diarrhoea, vomiting and constipation are the reason most people stop. They are worst in the first days after each dose increase and usually settle; a schedule held longer at one step is the standard answer, and it is a conversation with the prescriber rather than a reason to quit unannounced.

When to stop reading and call someone

Confusion, seizure, or being unable to treat it yourself. Anyone on insulin or a sulfonylurea starting one of these should have the doses of those reviewed rather than left as they were.

Separately, Wegovy carries a boxed warning. In rodents this molecule caused thyroid C-cell tumours at human-relevant doses. Whether it does so in people is unknown, and the label carries that as a boxed warning. It is contraindicated outright with a personal or family history of medullary thyroid carcinoma or MEN 2.

The other 13 common reactions on Wegovy's label

If you are thinking of switching

Low blood sugar is on the label of most drugs in this class, so a switch is not a reliable way out of it. What a switch does change is what you pay, and Wegovy is $349 a month at the maintenance dose here.

Every alternative to Wegovy, with each one's verified price and the date it was read →

All Wegovy side effects →Wegovy price and terms →Wegovy dose schedule →How long Wegovy takes to work →

Everything on Wegovy

Wegovy and low blood sugar, answered

Does Wegovy cause low blood sugar?: Yes — low blood sugar is listed among the common adverse reactions on Wegovy's FDA prescribing information, published 2026-06-30. Listed means it was seen often enough in the trials to be printed, not that it happens to everyone.
How long does Wegovy low blood sugar last?: It does not track the dose schedule, so it does not arrive with each increase and does not settle between them.
What helps with low blood sugar on Wegovy?: Knowing whether anything else you take is insulin or a sulfonylurea — glipizide, glimepiride, glyburide. If so, this is a conversation with the prescriber before the next dose increase, not after a bad episode. Carrying fast sugar if you are on either of those. Recognising the pattern: sweating, shakiness, sudden hunger, confusion. On these drugs it can be mistaken for the ordinary nausea. Testing rather than guessing, if you have a meter.
When is low blood sugar on Wegovy serious?: Confusion, seizure, or being unable to treat it yourself. Anyone on insulin or a sulfonylurea starting one of these should have the doses of those reviewed rather than left as they were.
Would switching drugs help?: Possibly, and possibly not — low blood sugar is listed on the labels of most drugs in this class, so a switch is not a way out of it by default. What a switch does change is the price: every verified route to each molecule is priced on this site with the date each figure was read.

Everything above is read from FDA prescribing information for WEGOVY, published 2026-06-30. Information only, not medical advice — a symptom that worries you is a call to your prescriber, not a search result.